Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs The Virtual NP

Mevo Health
Graded #326

Lower grade

vs+0.5999999999999943
The Virtual NP
Graded #314

Higher grade

The verdict

The Virtual NP takes it — 60.8/100 to 60.2/100, but only just.

The Virtual NP grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Virtual NP is a nurse-practitioner-led telehealth weight loss clinic prescribing FDA-approved branded GLP-1 medications, Zepbound (tirzepatide) and Wegovy (semaglutide), from Eli Lilly and Novo Nordisk. Mevo Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMevo Health +11
56
45
Dose & formulationMevo Health +30
83
53
Clinical oversightThe Virtual NP +27
67
94
Labs & monitoringThe Virtual NP +2
52
54
FulfillmentThe Virtual NP +7
57
64
Contract termsThe Virtual NP +35
20
55
Mevo Health · left barThe Virtual NP · right bar

The numbers

MetricMevo HealthThe Virtual NP
WeighScore60.2/10060.8/100
GradeCC
Scorecard rank#326#314
Semaglutide$199/mo (all doses, compounded)Not disclosed
Tirzepatide$259/mo (all doses, compounded)Not disclosed
CoverageCoverage not published7 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
The Virtual NP

Graded #314 · C

Strengths

  • FDA-approved branded Zepbound and Wegovy only, no compounded
  • Transparent fees: 99 visit or 75 per month membership
  • HSA/FSA accepted and prior authorization assistance offered
  • NP-led with same or next-day booking and home shipping

Where it loses points

  • Branded only, so medication cost is high and billed separately
  • Limited to seven states
  • No compounded lower-cost GLP-1 alternative
  • Single-provider practice may limit scale and hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard